SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039817
Filing Date
2023-08-08
Accepted
2023-08-08 16:12:24
Documents
78
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pcvx-20230630.htm   iXBRL 10-Q 3832510
2 EX-10.1 pcvx-ex10_1.htm EX-10.1 383974
3 EX-10.2 pcvx-ex10_2.htm EX-10.2 67583
4 EX-31.1 pcvx-ex31_1.htm EX-31.1 17656
5 EX-31.2 pcvx-ex31_2.htm EX-31.2 17663
6 EX-32.1 pcvx-ex32_1.htm EX-32.1 8894
  Complete submission text file 0000950170-23-039817.txt   12804472

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcvx-20230630_pre.xml EX-101.PRE 414374
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcvx-20230630_def.xml EX-101.DEF 249264
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcvx-20230630_cal.xml EX-101.CAL 51103
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcvx-20230630_lab.xml EX-101.LAB 525929
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcvx-20230630.xsd EX-101.SCH 73398
72 EXTRACTED XBRL INSTANCE DOCUMENT pcvx-20230630_htm.xml XML 2365033
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39323 | Film No.: 231151439
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences